# US 2026/0085088 A1 · Preparation of biologically active complexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085088 A1
- Document ID: US20260085088A1
- Status: Published application
- Kind: A1
- Application number: 19/205,790
- Filed: 2025-05-12
- Published: 2026-03-26
- Earliest claimed: 2017-05-14
- Assignees: Hamlet Pharma AB
- Applicants: Hamlet Pharma AB
- Inventors: Aftab NADEEM; Catharina SVANBORG; Chin Shing HO
- Web page: https://patentgrep.com/patent/US20260085088A1

## CPC

- A61K 38/17: from animals; from humans {(enzyme inhibitors A61K38/005)}
- C07K 1/107: by chemical modification of precursor peptides
- A61K 38/38: Albumins
- A61K 38/47: acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A61P 35/00: Antineoplastic agents
- C07K 1/34: by filtration, ultrafiltration or reverse osmosis
- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K 14/76: Albumins
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides a method for preparing a biologically active complex, said method comprising dissolving a mixture of a polypeptide element, such as alphalactalbumin or fragments thereof, in powder form and oleic acid or a pharmaceutically acceptable salt thereof also in solid form, in an aqueous solvent comprising a mixture of at least two and preferably three salts, wherein the method is carried out at moderate temperatures. The preparation does not require extensive heating and so is simple and efficient to carry out.

## Claims

### Claim at position 1

1-26. (canceled)

### Claim 27

A peptide of SEQ ID NO:6.

### Claim 28 (depends on 27)

A peptide according to claim 27, which is of SEQ ID NO:7.

### Claim 29 (depends on 27)

A biologically active complex comprising a peptide of claim 27 and oleic acid or a salt thereof.

### Claim 30 (depends on 29)

A biologically active complex according to claim 29 wherein the peptide is of SEQ ID NO:7.

### Claim 31 (depends on 29)

A method for preparing a biologically active complex of claim 29, said method comprising dissolving a polypeptide element and oleic acid or a pharmaceutically acceptable salt thereof in an aqueous solvent to form a solution, wherein the polypeptide element is in powder form and the oleic acid or pharmaceutically acceptable salt thereof is in solid form prior to the dissolving, and wherein the aqueous solvent comprises at least two salts, comprising a first salt selected from sodium chloride or potassium chloride and a second salt selected from disodium phosphate or mono-potassium phosphate, and wherein the method is performed at moderate temperature of up to 50° C.

### Claim 32 (depends on 31)

The method of claim 31, wherein the aqueous solvent further comprises a third salt selected from mono-sodium phosphate or mono-potassium phosphate.

### Claim 33 (depends on 31)

A method according to claim 31 wherein the moderate temperature is a temperature of from 10-40° C.

### Claim 34 (depends on 33)

A method according to claim 33 which is carried out at ambient temperature.

### Claim 35 (depends on 31)

A method according to claim 31, further comprising filtering a solution formed.

### Claim 36 (depends on 31)

A method according to claim 31, further comprising removing the solvent from the solution and obtaining the biologically active complex in solid form.

### Claim 37 (depends on 36)

A method according to claim 36, wherein the solvent is removed by lyophilisation.

### Claim 38 (depends on 31)

A method according to claim 31, wherein the polypeptide element is a peptide of SEQ ID NO:7.

### Claim 39 (depends on 31)

A method according to claim 31, wherein the first salt is sodium chloride.

### Claim 40 (depends on 31)

A method according to claim 31, wherein the second salt is disodium monophosphate.

### Claim 41 (depends on 32)

A method according to claim 32 wherein the third salt is mono-potassium phosphate

### Claim 42 (depends on 36)

A method according to claim 36, wherein the biologically active complex is reconstituted using sterile water just prior to use.

### Claim 43 (depends on 29)

A pharmaceutical composition comprising the biologically active complex according to claim 29.

### Claim 44 (depends on 29)

A nutraceutical composition comprising the biologically active complex according to claim 29.

### Claim 45 (depends on 29)

A method for treating or preventing cancer or a viral infection, said method comprising administering to a patient in need thereof an effective amount of the biologically active complex according to claim 29.

### Claim 46 (depends on 43)

A method for treating or preventing cancer or a viral infection, said method comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition according to claim 43.

### Claim 47 (depends on 44)

A method for treating or preventing cancer or a viral infection, said method comprising administering to a patient in need thereof an effective amount of the nutraceutical composition according to claim 44.
